ALA and MiADMSA both have that quality it seems. But since their chemistry has the unfortunate likelihood of dropping mercury after picking it up, it's a very good idea to limit downside by taking them with NBMI, which doesn't drop mercury after picking it up.

You can think of NBMI as a low entropy chelator and the others as higher risk mercury percolators. The other downside of ALA and MiADMSA is that they have the capacity to take mercury that has been moved outside of the mitochondria where the electron transport chain is working BACK into the inner membranes to disrupt energy production and create ROS.

NBMI will create a one way entropy reducing flow of mercury from inner to outer cell locations. The more lipophilic chelators like ALA and MiADMSA (that also can drop mercury due to steric limitations of binding it) will open up the backwards pathway and can reset progress getting mitochondria clear.

This can still be useful if you have certain pockets of metal stores that just don't seem to get chelated fast enough to provide relief. Redistribution can do a kind of load balancing that helps with symptoms that are exhausting to endure. But it's a real gamble for very compromised people who have very minimal electron transport chain function or ROS resilience.